Bjoern Peters Selected Research

Viral Antigens

1/2020	Epitope-specific airway-resident CD4+ T cell dynamics during experimental human RSV infection.
12/2015	RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bjoern Peters Research Topics

Disease

44	Infections 01/2024 - 09/2005
33	Hypersensitivity (Allergy) 11/2023 - 03/2007
31	Neoplasms (Cancer) 03/2024 - 09/2009
20	COVID-19 05/2024 - 01/2020
16	Communicable Diseases (Infectious Diseases) 11/2023 - 03/2007
11	Tuberculosis (Tuberculoses) 01/2024 - 05/2012
10	Whooping Cough (Pertussis) 08/2023 - 05/2014
9	Malaria 01/2023 - 04/2010
9	Asthma (Bronchial Asthma) 12/2020 - 08/2012
8	Inflammation (Inflammations) 04/2024 - 09/2012
8	Dengue (Dengue Fever) 01/2018 - 01/2015
7	Smallpox (Variola) 05/2016 - 09/2005
5	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 10/2009
5	Vaccinia 01/2022 - 09/2005
5	Parkinson Disease (Parkinson's Disease) 11/2021 - 01/2017
5	Human Influenza (Influenza) 02/2016 - 01/2007
4	Congenital Heart Defects (Congenital Heart Defect) 08/2014 - 01/2009
4	Aortic Coarctation 10/2008 - 10/2004
3	Disease Progression 05/2024 - 11/2021
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2019
3	Virus Diseases (Viral Diseases) 01/2016 - 08/2008
2	Critical Illness (Critically Ill) 05/2024 - 11/2023
2	Type 2 Diabetes Mellitus (MODY) 03/2024 - 05/2014
2	Vasculitis (Vasculitides) 01/2022 - 01/2020
2	Carcinogenesis 01/2022 - 01/2021
2	Atherosclerosis 01/2022 - 01/2020
2	Severe Dengue 01/2019 - 08/2015
2	Rhinitis 01/2018 - 08/2012
2	Drug-Related Side Effects and Adverse Reactions 01/2015 - 06/2012
2	HIV Infections (HIV Infection) 07/2010 - 11/2005
2	Arenaviridae Infections 06/2010 - 05/2010
2	Aseptic Meningitis 05/2010 - 12/2009
2	Lymphocytic Choriomeningitis 05/2010 - 12/2009
2	Fever (Fevers) 05/2010 - 12/2009
2	Aneurysm (Aneurysms) 01/2009 - 04/2006
2	Pathologic Constriction (Stenosis) 05/2008 - 10/2004
1	Prostatic Neoplasms (Prostate Cancer) 11/2023
1	Convalescence 10/2023
1	Squamous Cell Carcinoma of Head and Neck 01/2023
1	Adenocarcinoma 01/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023

Drug/Important Bio-Agent (IBA)

75	EpitopesIBA 03/2024 - 09/2005
51	VaccinesIBA 04/2024 - 09/2005
43	AntigensIBA 01/2024 - 09/2005
31	Peptides (Polypeptides)IBA 03/2024 - 09/2005
26	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2024 - 09/2005
24	Proteins (Proteins, Gene)FDA Link 02/2024 - 09/2005
15	AllergensIBA 12/2023 - 09/2009
9	CytokinesIBA 05/2024 - 07/2006
9	AutoantigensIBA 01/2023 - 09/2005
7	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2013
7	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2024 - 11/2012
7	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 02/2010
5	LigandsIBA 11/2023 - 11/2017
5	AntibodiesIBA 10/2023 - 12/2009
4	ChemokinesIBA 04/2024 - 03/2022
4	HLA-B57 antigenIBA 01/2022 - 01/2015
4	abacavir (Ziagen)FDA Link 01/2022 - 01/2015
4	SynucleinsIBA 11/2021 - 01/2017
4	Immunoglobulin E (IgE)IBA 01/2018 - 07/2012
3	HLA-DRB1 Chains (HLA DRB1)IBA 03/2024 - 02/2010
3	ProteomeIBA 01/2024 - 04/2023
3	Immune Checkpoint InhibitorsIBA 05/2023 - 01/2021
3	Interleukin-2 (IL2)IBA 01/2023 - 11/2010
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2019
2	Neutralizing AntibodiesIBA 10/2023 - 09/2006
2	Cancer VaccinesIBA 05/2023 - 01/2023
2	Complement System Proteins (Complement)IBA 01/2023 - 02/2016
2	Malaria VaccinesIBA 01/2023 - 10/2013
2	CD40 Ligand (CD40L)IBA 01/2023 - 11/2010
2	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 02/2016
2	Apolipoproteins B (ApoB)IBA 01/2022 - 01/2020
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 01/2020
2	BNT162 VaccineIBA 03/2021 - 01/2021
2	COVID-19 VaccinesIBA 03/2021 - 01/2021
2	Subunit VaccinesIBA 01/2021 - 05/2014
2	Acellular VaccinesIBA 01/2021 - 05/2014
2	HLA-DR Antigens (HLA-DR)IBA 01/2021 - 10/2013
2	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2021 - 03/2007
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2014
2	Viral AntigensIBA 01/2020 - 12/2015
2	Attenuated VaccinesIBA 12/2017 - 01/2017
2	Isoantigens (Alloantigen)IBA 01/2017 - 10/2012
2	Nevirapine (Viramune)FDA Link 01/2017 - 01/2015
2	Antiviral Agents (Antivirals)IBA 05/2015 - 03/2010
2	Histones (Histone)IBA 08/2014 - 09/2012
2	Hemagglutinins (Hemagglutinin)IBA 05/2014 - 01/2007
2	Coenzyme A (CoA)IBA 10/2008 - 04/2006
1	Interleukin-6 (Interleukin 6)IBA 02/2024
1	InflammasomesIBA 02/2024
1	Immunoglobulins (Immunoglobulin)IBA 11/2023
1	Viral RNAIBA 10/2023
1	Oncogene Proteins (Oncogene Protein)IBA 01/2023
1	Interleukin-7 (Interleukin 7)IBA 01/2023
1	HLA-DQ Antigens (HLA-DQ)IBA 01/2023

Therapy/Procedure

13	Immunotherapy 03/2024 - 08/2012
12	Therapeutics 05/2024 - 10/2004
8	Transplantation 01/2023 - 09/2009
6	Stents 03/2010 - 10/2004